Yasmin 20 Cycle Control - Yasmin 20 Versus Mercilon in Healthy Female Volunteers
Launched by BAYER · Feb 25, 2008
Trial Information
Current as of May 15, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Healthy female volunteer aged 18-35,
- • Smokers 18-30
- Exclusion Criteria:
- • Contraindications for using hormonal contraceptives
About Bayer
Bayer is a global healthcare and life sciences company dedicated to advancing health and well-being through innovative research and development. With a strong commitment to improving patient outcomes, Bayer conducts clinical trials across various therapeutic areas, including oncology, cardiology, and women's health. The company leverages cutting-edge science and technology to develop breakthrough therapies, while adhering to the highest standards of ethical practices and regulatory compliance. Through collaboration with healthcare professionals and research institutions, Bayer aims to bring transformative solutions to the market, ultimately enhancing the quality of life for patients worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Wien, , Austria
Kaunas, , Lithuania
Vilnius, , Lithuania
Helsinki, , Finland
Tartu, , Estonia
St. Poelten, , Austria
Horn, , Austria
Leibnitz, , Austria
Moedling, , Austria
Woergl, , Austria
Paernu, , Estonia
Talinn, , Estonia
Tampere, , Finland
Turku, , Finland
Patients applied
Trial Officials
Bayer Study Director
Study Director
Bayer
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials